What is SION's current ratio?

SION (SION) reported current ratio of 22.6× in Q1 2026.

How has SION's current ratio changed year-over-year?

SION's current ratio decreased by 21.3% year-over-year, from 28.7× to 22.6×.

What does current ratio mean?

Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.

SION SION Current ratio

Current ratio at other companies

Vertex PharmaceuticalsVRTX

3×+0.4×

AbbVieABBV

0.8×0.0×

Septerna, Inc.SEPN

4.7×-27.5×

BioCryst PharmaceuticalsBCRX

1.9×-1.0×

Denali Therapeutics Inc.DNLI

9.3×-0.3×

Neurocrine BiosciencesNBIX

2.9×-0.2×

Other financials

Income statement

See full

Operating income-$29.6M-50.6%

Net income-$26.8M-62.5%

EPS (diluted)-$0.60+3.2%

Balance sheet

See full

Cash & equivalents$64.3M-23.2%

Total debt$8.4M-11.8%

Total equity$288.2M-18.1%

Total assets$305.0M-17.5%

Cash flow

See full

Operating cash flow-$21.8M-34.1%

CapEx--100%

Free cash flow-$21.8M-33.4%

Valuation

See full

Market cap$1.8B—

Enterprise value$1.74B—

Returns & leverage

See full

Return on equity-26.7%—

Debt / equity0×0.0×

Where this comes from

Calculated from SION’s reported figures.

total current assets/total current liabilities=22.6×

Based on the most recent quarter.

The official record: SION’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about SION's current ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is SION's current ratio?: SION (SION) reported current ratio of 22.6× in Q1 2026.
How has SION's current ratio changed year-over-year?: SION's current ratio decreased by 21.3% year-over-year, from 28.7× to 22.6×.
What does current ratio mean?: Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.